MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 44 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $954,920 | +20.0% | 30,219 | -1.8% | 0.00% | – |
| Q2 2023 | $795,761 | +84.8% | 30,760 | +71.6% | 0.00% | – |
| Q1 2023 | $430,559 | +2591.0% | 17,925 | +2332.2% | 0.00% | – |
| Q3 2022 | $16,000 | +77.8% | 737 | +62.7% | 0.00% | – |
| Q2 2022 | $9,000 | – | 453 | +2057.1% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 21 | -93.1% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 303 | -9.3% | 0.00% | – |
| Q2 2021 | $6,000 | -88.0% | 334 | -86.6% | 0.00% | – |
| Q1 2021 | $50,000 | -84.9% | 2,500 | -86.9% | 0.00% | – |
| Q4 2020 | $332,000 | +228.7% | 19,038 | +260.2% | 0.00% | – |
| Q3 2020 | $101,000 | -19.8% | 5,286 | -18.7% | 0.00% | – |
| Q2 2020 | $126,000 | +147.1% | 6,498 | +76.7% | 0.00% | – |
| Q1 2020 | $51,000 | +920.0% | 3,678 | +1465.1% | 0.00% | – |
| Q4 2019 | $5,000 | +150.0% | 235 | +8.3% | 0.00% | – |
| Q3 2019 | $2,000 | – | 217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |